PDB Short entry for 3EOV HEADER ISOMERASE/IMMUNOSUPPRESSANT 29-SEP-08 3EOV TITLE CRYSTAL STRUCTURE OF CYCLOPHILIN FROM LEISHMANIA DONOVANI LIGATED WITH TITLE 2 CYCLOSPORIN A COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PPIASE, ROTAMASE, CYCLOPHILIN; COMPND 5 EC: 5.2.1.8; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CYCLOSPORIN A; COMPND 9 CHAIN: C, D; COMPND 10 SYNONYM: CICLOSPORIN, CICLOSPORINE; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LEISHMANIA DONOVANI; SOURCE 3 ORGANISM_TAXID: 5661; SOURCE 4 GENE: CYP; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: M15; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PQE32; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: TOLYPOCLADIUM INFLATUM; SOURCE 13 ORGANISM_TAXID: 29910 KEYWDS ISOMERASE-IMMUNOSUPPRESSANT COMPLEX, CYCLOPHILIN-CYCLOSPORIN COMPLEX, KEYWDS 2 CYCLOSPORIN A, IMMUNOSUPPRESSANT, CYCLOPHILIN EXPDTA X-RAY DIFFRACTION AUTHOR V.VENUGOPAL,D.DASGUPTA,A.K.DATTA,R.BANERJEE REVDAT 7 15-NOV-23 3EOV 1 LINK REVDAT 6 06-SEP-23 3EOV 1 SEQADV LINK REVDAT 5 27-JUL-11 3EOV 1 ATOM HEADER HETATM KEYWDS REVDAT 5 2 1 REMARK REVDAT SEQRES REVDAT 4 13-JUL-11 3EOV 1 VERSN REVDAT 3 15-JUN-11 3EOV 1 JRNL REVDAT 2 24-FEB-09 3EOV 1 VERSN REVDAT 1 11-NOV-08 3EOV 0 JRNL AUTH V.VENUGOPAL,A.K.DATTA,D.BHATTACHARYYA,D.DASGUPTA,R.BANERJEE JRNL TITL STRUCTURE OF CYCLOPHILIN FROM LEISHMANIA DONOVANI BOUND TO JRNL TITL 2 CYCLOSPORIN AT 2.6 A RESOLUTION: CORRELATION BETWEEN JRNL TITL 3 STRUCTURE AND THERMODYNAMIC DATA. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 65 1187 2009 JRNL REFN ISSN 0907-4449 JRNL PMID 19923714 JRNL DOI 10.1107/S0907444909034234 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH V.VENUGOPAL,B.SEN,A.K.DATTA,R.BANERJEE REMARK 1 TITL STRUCTURE OF CYCLOPHILIN FROM LEISHMANIA DONOVANI AT 1.97 A REMARK 1 TITL 2 RESOLUTION. REMARK 1 REF ACTA CRYSTALLOGR.,SECT.F V. 63 60 2007 REMARK 1 REFN ESSN 1744-3091 REMARK 1 PMID 17277440 REMARK 1 DOI 10.1107/S1744309106056351 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.DUTTA,P.DELHI,K.M.SINHA,R.BANERJEE,A.K.DATTA REMARK 1 TITL LACK OF ABUNDANCE OF CYTOPLASMIC CYCLOSPORIN A- BINDING REMARK 1 TITL 2 PROTEIN RENDERS FREE-LIVING LEISHMANIA DONOVANI RESISTANT TO REMARK 1 TITL 3 CYCLOSPORIN A. REMARK 1 REF J.BIOL.CHEM. V. 276 19294 2001 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 11278494 REMARK 1 DOI 10.1074/JBC.M009379200 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.48 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 780102.190 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 12040 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 623 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1968 REMARK 3 BIN R VALUE (WORKING SET) : 0.3150 REMARK 3 BIN FREE R VALUE : 0.2110 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 0.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 2 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.149 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2728 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 76 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 52.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 12.41000 REMARK 3 B22 (A**2) : 2.40000 REMARK 3 B33 (A**2) : -14.81000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.40000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM SIGMAA (A) : 0.43 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.53 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.780 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 57.60 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : CSA.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : CSA.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3EOV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-SEP-08. REMARK 100 THE DEPOSITION ID IS D_1000049590. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-08 REMARK 200 TEMPERATURE (KELVIN) : 293.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : OSMIC MAXFLUX CONFOCAL MULTILAY REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 300 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12040 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.3 REMARK 200 DATA REDUNDANCY : 4.110 REMARK 200 R MERGE (I) : 0.05200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.5 REMARK 200 DATA REDUNDANCY IN SHELL : 5.30 REMARK 200 R MERGE FOR SHELL (I) : 0.25100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2HAQ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.02M TRIS, 15% PEG3350, 0.1M NACL, REMARK 280 0.02% AZIDE, PH 8.5, 6% ETHYL ALCOHOL, CONCENTRATION: 10 MG/ML 1: REMARK 280 1 CYCLOPHILIN-CYCLOSPORIN COMPLEX, TEMPERATURE 292K, BATCH REMARK 280 METHOD, PH 8.50, SMALL TUBES REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 34.90500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.56250 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 34.90500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 41.56250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. REMARK 400 HERE, CYCLOSPORIN A IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 THE CYCLOSPORIN A IS CYCLIC PEPTIDE, A MEMBER OF IMMUNOSUPPRESSANT REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CYCLOSPORIN A REMARK 400 CHAIN: C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION REMARK 400 IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 16 REMARK 465 HIS A 17 REMARK 465 HIS A 18 REMARK 465 HIS A 19 REMARK 465 HIS A 20 REMARK 465 HIS A 21 REMARK 465 HIS B 16 REMARK 465 HIS B 17 REMARK 465 HIS B 18 REMARK 465 HIS B 19 REMARK 465 HIS B 20 REMARK 465 HIS B 21 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 22 CG CD OE1 OE2 REMARK 470 GLN A 81 CG CD OE1 NE2 REMARK 470 GLU B 22 CG CD OE1 OE2 REMARK 470 GLN B 81 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 36 81.17 53.34 REMARK 500 SER A 37 -18.14 61.19 REMARK 500 ALA A 52 76.10 -159.68 REMARK 500 ASP A 73 -7.03 88.28 REMARK 500 PHE A 83 -76.64 -150.11 REMARK 500 ASN A 92 -21.69 -148.84 REMARK 500 ASP A 156 145.85 -170.33 REMARK 500 THR A 167 155.32 -46.19 REMARK 500 SER A 171 170.77 -57.02 REMARK 500 PRO B 23 178.16 -57.68 REMARK 500 ASP B 36 88.70 63.90 REMARK 500 SER B 37 -17.31 73.73 REMARK 500 ALA B 52 78.34 -163.25 REMARK 500 GLU B 66 -60.40 -29.60 REMARK 500 ASP B 73 -2.23 74.66 REMARK 500 ARG B 78 113.75 -163.84 REMARK 500 PHE B 83 -68.67 -131.33 REMARK 500 ASN B 124 -166.41 -161.13 REMARK 500 THR B 167 156.07 -40.19 REMARK 500 ASN B 170 -168.38 -127.12 REMARK 500 SER B 171 156.49 -46.83 REMARK 500 HIS B 172 -6.38 69.63 REMARK 500 MVA C 4 73.73 -118.35 REMARK 500 VAL C 9 98.72 72.85 REMARK 500 MLE C 10 -152.29 -108.96 REMARK 500 VAL D 9 99.63 76.43 REMARK 500 MLE D 10 -145.39 -108.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF CYCLOSPORIN A REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BCK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 C REMARK 900 RELATED ID: 1C5F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CYCLOPHILIN-LIKE DOMAIN FROM BRUGIA MALAYI REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1CSA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF E.COLI CYCLOPHILIN (F112W) COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 1CWA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 1CWB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 5 REMARK 900 RELATED ID: 1CWC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 D REMARK 900 RELATED ID: 1CWH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A MODIFIED AT POSITION 7 REMARK 900 RELATED ID: 1CWI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITION 7 REMARK 900 RELATED ID: 1CWJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7. REMARK 900 RELATED ID: 1CWK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7. REMARK 900 RELATED ID: 1CWL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH NODIFIED REMARK 900 CYCLOSPORIN C AT POSITIONS 1, AND 9 REMARK 900 RELATED ID: 1CYA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WIYH CYCLOSPORIN A REMARK 900 RELATED ID: 1CYB RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1CYN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN B COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 1IKF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CTCLOSPORIN-FAB COMPLEX REMARK 900 RELATED ID: 1M63 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN-CYCLOSPORIN COMPLEX REMARK 900 RELATED ID: 1MF8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH HUMAN REMARK 900 CYCLOPHILIN AND CYCLOSPORIN A REMARK 900 RELATED ID: 1MIK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 6 REMARK 900 RELATED ID: 1QNG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN COMPLEXED REMARK 900 WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1QNH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN (DOUBLE REMARK 900 MUTANT) COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1XQ7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYCLOPHILIN COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 2ESL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN C COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2OJU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN J COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2POY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CRYPTOSPORIDIUM PARVUM IOWA II CYCLOPHILIN A REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 2RMA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2RMB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 5 REMARK 900 RELATED ID: 2RMC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MURINE CYCLOPHILIN C COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 2WFJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PPIASE DOMAIN OF HUMAN CYCLOPHILIN G REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 2X2C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ACETYL-CYPA COMPLEXED WITH CYCLOSPORINE A REMARK 900 RELATED ID: 2X7K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PPIL1 COMPLEXED WITH CYCLOSPORINE A REMARK 900 RELATED ID: 2Z6W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D IN COMPLEX WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 3BO7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CYCLOSPHILIN A FROM TOXOPLASMA GONDII REMARK 900 COMPLEXED WIT CYCLOSPORIN A REMARK 900 RELATED ID: 3CYS RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE HUMAN CYCLOSPORIN A COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 2HAQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NATIVE CYCLOPHILIN FROM LEISHMANIA DONOVANI AT REMARK 900 1.97 A RESOLUTION REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE N-TERMINAL 5 RESIDUES 'HHHHHH' IN CHAINS A AND B IS AN REMARK 999 ENGINEERED EXPRESSION TAG DBREF 3EOV A 22 187 UNP Q9U9R3 Q9U9R3_LEIDO 22 187 DBREF 3EOV B 22 187 UNP Q9U9R3 Q9U9R3_LEIDO 22 187 DBREF 3EOV C 1 11 NOR NOR00033 NOR00033 1 11 DBREF 3EOV D 1 11 NOR NOR00033 NOR00033 1 11 SEQADV 3EOV HIS A 16 UNP Q9U9R3 EXPRESSION TAG SEQADV 3EOV HIS A 17 UNP Q9U9R3 EXPRESSION TAG SEQADV 3EOV HIS A 18 UNP Q9U9R3 EXPRESSION TAG SEQADV 3EOV HIS A 19 UNP Q9U9R3 EXPRESSION TAG SEQADV 3EOV HIS A 20 UNP Q9U9R3 EXPRESSION TAG SEQADV 3EOV HIS A 21 UNP Q9U9R3 EXPRESSION TAG SEQADV 3EOV HIS B 16 UNP Q9U9R3 EXPRESSION TAG SEQADV 3EOV HIS B 17 UNP Q9U9R3 EXPRESSION TAG SEQADV 3EOV HIS B 18 UNP Q9U9R3 EXPRESSION TAG SEQADV 3EOV HIS B 19 UNP Q9U9R3 EXPRESSION TAG SEQADV 3EOV HIS B 20 UNP Q9U9R3 EXPRESSION TAG SEQADV 3EOV HIS B 21 UNP Q9U9R3 EXPRESSION TAG SEQRES 1 A 172 HIS HIS HIS HIS HIS HIS GLU PRO GLU VAL THR ALA LYS SEQRES 2 A 172 VAL TYR PHE ASP VAL MET ILE ASP SER GLU PRO LEU GLY SEQRES 3 A 172 ARG ILE THR ILE GLY LEU PHE GLY LYS ASP ALA PRO LEU SEQRES 4 A 172 THR THR GLU ASN PHE ARG GLN LEU CYS THR GLY GLU HIS SEQRES 5 A 172 GLY PHE GLY TYR LYS ASP SER ILE PHE HIS ARG VAL ILE SEQRES 6 A 172 GLN ASN PHE MET ILE GLN GLY GLY ASP PHE THR ASN PHE SEQRES 7 A 172 ASP GLY THR GLY GLY LYS SER ILE TYR GLY GLU LYS PHE SEQRES 8 A 172 ALA ASP GLU ASN LEU ASN VAL LYS HIS PHE VAL GLY ALA SEQRES 9 A 172 LEU SER MET ALA ASN ALA GLY PRO ASN THR ASN GLY SER SEQRES 10 A 172 GLN PHE PHE ILE THR THR ALA PRO THR PRO TRP LEU ASP SEQRES 11 A 172 GLY ARG HIS VAL VAL PHE GLY LYS VAL LEU ASP GLY MET SEQRES 12 A 172 ASP VAL VAL LEU ARG ILE GLU LYS THR LYS THR ASN SER SEQRES 13 A 172 HIS ASP ARG PRO VAL LYS PRO VAL LYS ILE VAL ALA SER SEQRES 14 A 172 GLY GLU LEU SEQRES 1 B 172 HIS HIS HIS HIS HIS HIS GLU PRO GLU VAL THR ALA LYS SEQRES 2 B 172 VAL TYR PHE ASP VAL MET ILE ASP SER GLU PRO LEU GLY SEQRES 3 B 172 ARG ILE THR ILE GLY LEU PHE GLY LYS ASP ALA PRO LEU SEQRES 4 B 172 THR THR GLU ASN PHE ARG GLN LEU CYS THR GLY GLU HIS SEQRES 5 B 172 GLY PHE GLY TYR LYS ASP SER ILE PHE HIS ARG VAL ILE SEQRES 6 B 172 GLN ASN PHE MET ILE GLN GLY GLY ASP PHE THR ASN PHE SEQRES 7 B 172 ASP GLY THR GLY GLY LYS SER ILE TYR GLY GLU LYS PHE SEQRES 8 B 172 ALA ASP GLU ASN LEU ASN VAL LYS HIS PHE VAL GLY ALA SEQRES 9 B 172 LEU SER MET ALA ASN ALA GLY PRO ASN THR ASN GLY SER SEQRES 10 B 172 GLN PHE PHE ILE THR THR ALA PRO THR PRO TRP LEU ASP SEQRES 11 B 172 GLY ARG HIS VAL VAL PHE GLY LYS VAL LEU ASP GLY MET SEQRES 12 B 172 ASP VAL VAL LEU ARG ILE GLU LYS THR LYS THR ASN SER SEQRES 13 B 172 HIS ASP ARG PRO VAL LYS PRO VAL LYS ILE VAL ALA SER SEQRES 14 B 172 GLY GLU LEU SEQRES 1 C 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 D 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA HET DAL C 1 5 HET MLE C 2 9 HET MLE C 3 9 HET MVA C 4 8 HET BMT C 5 13 HET ABA C 6 6 HET SAR C 7 5 HET MLE C 8 9 HET MLE C 10 9 HET DAL D 1 5 HET MLE D 2 9 HET MLE D 3 9 HET MVA D 4 8 HET BMT D 5 13 HET ABA D 6 6 HET SAR D 7 5 HET MLE D 8 9 HET MLE D 10 9 HETNAM DAL D-ALANINE HETNAM MLE N-METHYLLEUCINE HETNAM MVA N-METHYLVALINE HETNAM BMT 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM SAR SARCOSINE FORMUL 3 DAL 2(C3 H7 N O2) FORMUL 3 MLE 8(C7 H15 N O2) FORMUL 3 MVA 2(C6 H13 N O2) FORMUL 3 BMT 2(C10 H19 N O3) FORMUL 3 ABA 2(C4 H9 N O2) FORMUL 3 SAR 2(C3 H7 N O2) FORMUL 5 HOH *76(H2 O) HELIX 1 1 ALA A 52 GLY A 65 1 14 HELIX 2 2 THR A 141 ASP A 145 5 5 HELIX 3 3 GLY A 157 GLU A 165 1 9 HELIX 4 4 ASN A 170 ARG A 174 5 5 HELIX 5 5 ALA B 52 GLY B 65 1 14 HELIX 6 6 THR B 141 ASP B 145 5 5 HELIX 7 7 GLY B 157 GLU B 165 1 9 HELIX 8 8 ASN B 170 ARG B 174 5 5 SHEET 1 AA 8 ARG A 78 ILE A 80 0 SHEET 2 AA 8 MET A 84 GLY A 87 -1 O MET A 84 N ILE A 80 SHEET 3 AA 8 PHE A 134 THR A 137 -1 O PHE A 134 N GLY A 87 SHEET 4 AA 8 ALA A 119 MET A 122 -1 O ALA A 119 N THR A 137 SHEET 5 AA 8 VAL A 150 ASP A 156 -1 N PHE A 151 O LEU A 120 SHEET 6 AA 8 GLU A 38 LEU A 47 -1 O THR A 44 N LEU A 155 SHEET 7 AA 8 LYS A 28 ILE A 35 -1 O VAL A 29 N ILE A 45 SHEET 8 AA 8 VAL A 179 GLU A 186 -1 O LYS A 180 N MET A 34 SHEET 1 BA 8 ARG B 78 ILE B 80 0 SHEET 2 BA 8 MET B 84 GLY B 87 -1 O MET B 84 N ILE B 80 SHEET 3 BA 8 PHE B 134 THR B 137 -1 O PHE B 134 N GLY B 87 SHEET 4 BA 8 ALA B 119 MET B 122 -1 O ALA B 119 N THR B 137 SHEET 5 BA 8 VAL B 150 ASP B 156 -1 N PHE B 151 O LEU B 120 SHEET 6 BA 8 PRO B 39 LEU B 47 -1 O THR B 44 N LEU B 155 SHEET 7 BA 8 LYS B 28 MET B 34 -1 O VAL B 29 N ILE B 45 SHEET 8 BA 8 LYS B 180 GLU B 186 -1 O LYS B 180 N MET B 34 LINK C DAL C 1 N MLE C 2 1555 1555 1.33 LINK N DAL C 1 C ALA C 11 1555 1555 1.33 LINK C MLE C 2 N MLE C 3 1555 1555 1.33 LINK C MLE C 3 N MVA C 4 1555 1555 1.33 LINK C MVA C 4 N BMT C 5 1555 1555 1.33 LINK C BMT C 5 N ABA C 6 1555 1555 1.33 LINK C ABA C 6 N SAR C 7 1555 1555 1.33 LINK C SAR C 7 N MLE C 8 1555 1555 1.33 LINK C MLE C 8 N VAL C 9 1555 1555 1.33 LINK C VAL C 9 N MLE C 10 1555 1555 1.33 LINK C MLE C 10 N ALA C 11 1555 1555 1.33 LINK C DAL D 1 N MLE D 2 1555 1555 1.33 LINK N DAL D 1 C ALA D 11 1555 1555 1.33 LINK C MLE D 2 N MLE D 3 1555 1555 1.33 LINK C MLE D 3 N MVA D 4 1555 1555 1.33 LINK C MVA D 4 N BMT D 5 1555 1555 1.34 LINK C BMT D 5 N ABA D 6 1555 1555 1.32 LINK C ABA D 6 N SAR D 7 1555 1555 1.34 LINK C SAR D 7 N MLE D 8 1555 1555 1.33 LINK C MLE D 8 N VAL D 9 1555 1555 1.34 LINK C VAL D 9 N MLE D 10 1555 1555 1.33 LINK C MLE D 10 N ALA D 11 1555 1555 1.33 SITE 1 AC1 17 ARG A 78 PHE A 83 GLN A 86 GLY A 95 SITE 2 AC1 17 ALA A 123 ASN A 124 GLN A 133 TRP A 143 SITE 3 AC1 17 HIS A 148 PRO B 127 TRP B 143 ARG B 147 SITE 4 AC1 17 HOH C2001 MLE D 3 BMT D 5 MLE D 10 SITE 5 AC1 17 ALA D 11 SITE 1 AC2 17 PRO A 127 TRP A 143 ARG A 147 ARG B 78 SITE 2 AC2 17 PHE B 83 GLN B 86 GLY B 95 ALA B 123 SITE 3 AC2 17 ASN B 124 GLN B 133 PHE B 135 TRP B 143 SITE 4 AC2 17 HIS B 148 MLE C 3 BMT C 5 MLE C 10 SITE 5 AC2 17 ALA C 11 CRYST1 69.810 83.125 73.580 90.00 103.03 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014325 0.000000 0.003315 0.00000 SCALE2 0.000000 0.012030 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013950 0.00000